About the journal
Molecular Cancer Research is a journal published by American Association for Cancer Research in United States. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- American Association for Cancer Research
- ISSN
- 1541-7786 · 1557-3125
- Country
- United States
- Access
- Not open access / not declared
- Official website
- http://mcr.aacrjournals.org/
Index listings
- MEDLINE · 2002-01-01
- PUBMED · 2017-02-09
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 184 days received→accepted — computed from PubMed (n=99)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
4959
Last recorded publication year
2026
h-index
156
i10-index
2703
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 81%
- ORCID iDs in current deposits
- 77%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Alternate titles
- MCR
- Source type
- journal
- NLM unique ID (PubMed)
- 101150042
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- RNA modifications and cancer
Show all subjects (50)
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Ubiquitin and proteasome pathways
- Ubiquitin and proteasome pathways
- DNA Repair Mechanisms
- DNA Repair Mechanisms
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Hippo pathway signaling and YAP/TAZ
- Hippo pathway signaling and YAP/TAZ
- PI3K/AKT/mTOR signaling in cancer
- PI3K/AKT/mTOR signaling in cancer
- Cancer Research and Treatments
- Cancer Research and Treatments
- Cell Adhesion Molecules Research
- Cell Adhesion Molecules Research
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- Microtubule and mitosis dynamics
- Microtubule and mitosis dynamics
- Cancer-related gene regulation
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Cancer-related gene regulation
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- RNA Research and Splicing
- RNA Research and Splicing
- Cancer, Lipids, and Metabolism
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- PARP inhibition in cancer therapy
- PARP inhibition in cancer therapy
- Cell death mechanisms and regulation
- Cell death mechanisms and regulation
- Melanoma and MAPK Pathways
- Melanoma and MAPK Pathways
- Wnt/β-catenin signaling in development and cancer
- Wnt/β-catenin signaling in development and cancer
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ